Latest News

(UroToday.com) Most patients newly diagnosed with bladder cancer have non-muscle invasive disease (NMIBC). For patients with intermediate or high-risk NMIBC and those with carcinoma in situ (CIS), adjuvant treatment with BCG is guideline-recommended on the basis of proven benefits in disease recurrence. While BCG is efficacious, many patients eventually develop BCG-unresponsive disease and are at risk […]

(UroToday.com) Increasing utilization of cross-sectional imaging in primary care and emergency departments had led to an increase in the incidental diagnosis of renal masses. While the majority of these are renal cell carcinoma, a number of other entities are on the differential diagnosis including renal oncocytomas. Long-term outcomes of patients who undergo surgery for renal oncocytomas […]

(UroToday.com) As part of the Crossfire Controversies in Urology session at the AUA 2020 virtual annual meeting, Dr. Craig Comiter and Dr. Arthur Mourtzinos discussed the pros and cons of whether urodynamics is needed in the workup of post-prostatectomy incontinence prior to the placement of a male sling. Moderator Dr. Jaspreet Sandhu notes that in the […]

(UroToday.com) The TNM grading system for renal cell carcinoma (RCC) has been established and widely used for many years. In it, T3 is defined by a tumor that extends into major veins or perinephric tissues but not into the ipsilateral adrenal gland and not beyond the Gerota fascia. This is subdivided into T3a which is […]

(UroToday.com) Most patients newly diagnosed with bladder cancer have non-muscle invasive disease (NMIBC). For patients with intermediate or high-risk non muscle invasive bladder cancer (NMIBC) and those with carcinoma in situ (CIS), adjuvant treatment with BCG is guideline-recommended on the basis of proven benefits in disease recurrence. While BCG is efficacious, many patients (up to […]

(UroToday.com) As part of the Crossfire Controversies in Urology session at the AUA 2020 Virtual Annual Meeting, a group of panelists discussed the pros and cons of whether urodynamics are needed in the workup of post-prostatectomy incontinence under the guidance of moderator Jaspreet Sandhu, MD. Dr. Sandhu notes that in the Incontinence After Prostate Treatment: […]

(UroToday.com) In a plenary session at the American Urologic Association (AUA) 2020 Virtual Annual Meeting, Curtis Pettaway, MD moderated a session of second opinion cases focusing on alternatives to partial penectomy in patients with distal penile cancer along with panelists Drs. Phillippe Spiess, R.J. Karnes, and Karen Hoffman, who discussed a number of alternative treatments.

(UroToday.com) In the context of significant operative slow-downs as a result of COVID-19, there has been a renewed interest in the effect of treatment delays in urologic oncology. In a podium presentation at the American Urologic Association Virtual Annual Meeting, Dr. Devin Patel and colleagues present an analysis assessing the effect time to definitive surgical treatment on […]

(UroToday.com) Patients who undergo surgical resection of renal cancers are at risk of chronic kidney disease (CKD). The involvement of nephrologists, through nephrology referral for at-risk patients, is recommended per 2017 American Urologic Association guidelines, although adherence and its effects are uncertain. In a podium presentation at the American Urologic Association (AUA) Virtual Annual Meeting, […]

(UroToday.com) At the 2020 virtual AUA annual meeting, a panel discussion was held to evaluate fertility, hypogonadism and sexual function among patients with testis cancer. Moderator Mohit Khera, MD, MBA, MPH, presented a case of a 29-year-old man who presented with a two-month history of a right testicular mass, denying any testis pain or any recent […]